8-hydroxyquinoline: chronic toxicity and inhibitory effect on the carcinogenicity of N-2-fluorenylacetamide.
D000081:Acetamides / Q000009:adverse effects / Q000037:antagonists & inhibitors; D000577:Amides / Q000037:antagonists & inhibitors*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D005449:Fluorenes / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D006400:Hematocrit; D006486:Hemosiderosis / Q000378:metabolism; D007501:Iron / Q000378:metabolism; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008113:Liver Neoplasms / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009369:Neoplasms / Q000139:chemically induced; D009929:Organ Size; D011804:Quinolines / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000187:drug effects; D013997:Time Factors
D000081:Acetamides; D000577:Amides; D002273:Carcinogens; D005449:Fluorenes; D011804:Quinolines; D007501:Iron